Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
21
References
42
Citations
NaN
KQI